Prof. Peng Yuan 袁芃
Chief Physician, Professor
Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences (National Cancer Center), Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Medical oncology focusing on breast cancer, brain metastases from breast cancer, lung cancer, soft tissue sarcoma, and metastatic prostate cancer.
Dr. Yuan holds a PhD and has over 30 years of experience in medical oncology. Trained under Academicians Sun Yan and Xu Binghe, Dr. Yuan focuses on comprehensive treatment for breast cancer, lung cancer, gastrointestinal tumors, and soft tissue sarcoma. Research has been published in JAMA. Honors include the Second Prize of National Science and Technology Progress Award.
Professional roles
- Vice Chair, Breast Cancer Professional Committee, China Anti-Cancer Association
- Standing Committee Member, Oncology Physicians Branch, Chinese Medical Doctor Association
- Chair, Beijing Cancer Prevention and Control Society
Name order: in Chinese the family name comes first (Yuan Peng). Papers usually list the name as Peng Yuan or Yuan P.
Selected publications
165 papers on PubMed matched by name and affiliation; 57 as first or senior author since 2016. Most recent first- or senior-author papers:
- Genes Dis, 2027 (senior author): Multi-omics studies identified the molecular network of mitochondrial dysfunction in the pathogenesis of breast cancer. PubMed 42831172
- Front Oncol, 2026 (senior author): Plasma multi-omics reveals molecular remodeling and prognostic biomarkers in advanced breast cancer treated with trastuzumab deruxtecan. PubMed 42827766
- JAMA Oncol, 2026 (first author): Fovinaciclib for First-Line Therapy of Advanced Breast Cancer: A Randomized Clinical Trial. PubMed 42224659
- J Natl Cancer Cent, 2026 (senior author): MCLAM: a cost-effective deep learning model for predicting recurrence risk in HR+/HER2- breast cancer-a multi-center study in a Chinese cohort. PubMed 42282128
- Biomed Environ Sci, 2026 (senior author): An Exploratory Study on Prognostic Prediction and Interpretability Analysis in Early-stage Triple-negative Breast Cancer Using Pathological Images. PubMed 41944767
- Apoptosis, 2026 (senior author): A novel triaptosis-related prognostic signature to assess the clinical value in HER2-low breast cancer: evidence from clinical cohorts and experimental validation. PubMed 41793564
- Cancer Pathog Ther, 2026 (senior author): Trastuzumab deruxtecan in advanced breast cancer patients with brain metastases or leptomeningeal metastases. PubMed 41488702
- J Transl Med, 2025 (senior author): Integrative pan-cancer analysis of intratumoral microbial communities for biomarker discovery and diagnostic modeling. PubMed 41291716
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion